Skip to main content
. Author manuscript; available in PMC: 2021 May 8.
Published in final edited form as: Oncol Nurs Forum. 2019 Mar 1;46(2):228–237. doi: 10.1188/19.ONF.228-237

Table 2.

Mean (M) and Standard Deviation (SD) of Individual Symptoms and Health-Related Quality of Life by Time (N = 327)

Variable Start of post-induction therapy
(T1)
4 months post- induction therapy
(T2)
8 months post- induction therapy
(T3)
Start of maintenance therapy
(T4)
n M (SD) n M (SD) n M (SD) n M (SD)
Fatigue 300 53.87
(10.01)
292 50.03
(10.56)
241 48.22
(9.23)
222 46.60
(8.11)
Sleep Disturbance 296 2.66
(0.75)
286 2.75
(0.79)
240 2.75
(0.78)
219 2.69
(0.81)
Pain 297 2.67
(2.33)
287 1.67
(2.22)
239 1.37
(1.81)
220 1.34
(1.85)
Nausea 295 15.12
(21.67)
286 14.83
(21.84)
237 15.33
(21.35)
221 11.24
(18.33)
Depression 297 51.46
(9.88)
287 50.66
(10.52)
234 49.33
(10.23)
217 47.92
(8.75)
Health-Related Quality of Life 292 70.08
(15.66)
n/a n/a n/a n/a 219 75.77
(14.36)